[
  {
    "id": "10665-354214",
    "type": "report",
    "title": "Предварительные рекомендации по применению инактивированной вакцины CoronaVac против COVID-19, разработанной Sinovac: Временное руководство (Первый выпуск 24 мая 2021 г., Обновлено 21 октября 2021 г., Обновлено 15 марта 2022 г.)",
    "author": [
      {
        "literal": "Всемирная организация здравоохранения"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2022,
          5,
          11
        ]
      ]
    },
    "publisher": "Всемирная организация здравоохранения. Европейское региональное бюро",
    "URL": "https://iris.who.int/handle/10665/354214",
    "language": "ru"
  },
  {
    "id": "10665-354214.sec-004.1",
    "type": "document",
    "issued": {
      "date-parts": [
        [
          2022
        ]
      ]
    },
    "URL": "https://www.who.int/immunization/sage/Guidelines_development_recommendations.pdf"
  },
  {
    "id": "10665-354214.sec-004.2",
    "type": "document",
    "issued": {
      "date-parts": [
        [
          2022
        ]
      ]
    },
    "URL": "https://apps.who.int/iris/handle/10665/337569"
  },
  {
    "id": "10665-354214.sec-004.3",
    "type": "document",
    "issued": {
      "date-parts": [
        [
          2022
        ]
      ]
    },
    "URL": "https://www.who.int/publications/i/item/WHO-2019-nCoV-Vaccines-SAGE-Prioritization-2022.1"
  },
  {
    "id": "10665-354214.sec-004.4",
    "type": "document",
    "issued": {
      "date-parts": [
        [
          2022
        ]
      ]
    },
    "URL": "https://www.who.int/publications/i/item/who-sage-values-framework-for-the-allocation-and-prioritization-of-covid-19-vaccination"
  },
  {
    "id": "10665-354214.sec-004.5",
    "type": "document",
    "issued": {
      "date-parts": [
        [
          2022
        ]
      ]
    },
    "URL": "https://apps.who.int/iris/handle/10665/341455"
  },
  {
    "id": "10665-354214.sec-004.6",
    "type": "article-journal",
    "issued": {
      "date-parts": [
        [
          2021
        ]
      ]
    },
    "DOI": "10.1056/NEJMoa2107715"
  },
  {
    "id": "10665-354214.sec-004.7",
    "type": "document",
    "issued": {
      "date-parts": [
        [
          2021
        ]
      ]
    },
    "DOI": "10.1101/2021.08.03.21261544"
  },
  {
    "id": "10665-354214.sec-004.8",
    "type": "document",
    "issued": {
      "date-parts": [
        [
          2021
        ]
      ]
    },
    "DOI": "10.1101/2021.07.23.21261026"
  },
  {
    "id": "10665-354214.sec-004.9",
    "type": "article-journal",
    "issued": {
      "date-parts": [
        [
          2022
        ]
      ]
    }
  },
  {
    "id": "10665-354214.sec-004.10",
    "type": "document",
    "DOI": "10.2139/ssrn.4005130",
    "URL": "https://ssrn.com/abstract=4005130"
  },
  {
    "id": "10665-354214.sec-004.11",
    "type": "document",
    "issued": {
      "date-parts": [
        [
          2021
        ]
      ]
    },
    "URL": "https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE-recommendation-heterologous-schedules"
  },
  {
    "id": "10665-354214.sec-004.12",
    "type": "document",
    "issued": {
      "date-parts": [
        [
          2021
        ]
      ]
    },
    "DOI": "10.1101/2021.10.29.21265248",
    "URL": "https://doi.org/10.1101/2021.10.29.21265248"
  },
  {
    "id": "10665-354214.sec-004.13",
    "type": "document",
    "issued": {
      "date-parts": [
        [
          2021
        ]
      ]
    },
    "URL": "https://www.who.int/publications/i/item/who-sage-roadmap-for-prioritizing-uses-of-covid-19-vaccines-in-the-context-of-limited-supply"
  },
  {
    "id": "10665-354214.sec-004.14",
    "type": "article-journal",
    "issued": {
      "date-parts": [
        [
          2021
        ]
      ]
    },
    "DOI": "10.1001/jamanetworkopen.2021.20456"
  },
  {
    "id": "10665-354214.sec-004.15",
    "type": "article-journal",
    "issued": {
      "date-parts": [
        [
          2020
        ]
      ]
    },
    "DOI": "10.1136/bmj.m3320"
  },
  {
    "id": "10665-354214.sec-004.16",
    "type": "document",
    "issued": {
      "date-parts": [
        [
          2021
        ]
      ]
    },
    "DOI": "10.1101/2021.12.14.21267777"
  },
  {
    "id": "10665-354214.sec-004.17",
    "type": "document",
    "issued": {
      "date-parts": [
        [
          2022
        ]
      ]
    },
    "URL": "https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE_recommendation-immunocompromised-persons"
  },
  {
    "id": "10665-354214.sec-004.18",
    "type": "document",
    "DOI": "10.1126/sciimmunol.abn8014"
  },
  {
    "id": "10665-354214.sec-004.19",
    "type": "document",
    "issued": {
      "date-parts": [
        [
          2022
        ]
      ]
    },
    "URL": "https://apps.who.int/iris/handle/10665/334294"
  }
]
